SOST/pcDNA3.1+ Citations (4)

Originally described in: SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.
Semenov M, Tamai K, He X J Biol Chem. 2005 Jul 22. 280(29):26770-5. PubMed Journal

---

Articles Citing SOST/pcDNA3.1+

Articles
Sclerostin-erbB-3 interactions: modulation of erbB-3 activity by sclerostin. Craig TA, Kumar R. Biochem Biophys Res Commun. 2010 Nov 12;402(2):421-4. doi: 10.1016/j.bbrc.2010.10.048. Epub 2010 Oct 14. PubMed
A complex interaction between Wnt signaling and TNF-alpha in nucleus pulposus cells. Hiyama A, Yokoyama K, Nukaga T, Sakai D, Mochida J. Arthritis Res Ther. 2013 Nov 14;15(6):R189. doi: 10.1186/ar4379. PubMed
A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia. Khosravi R, Sodek KL, Xu WP, Bais MV, Saxena D, Faibish M, Trackman PC. PLoS One. 2014 Jun 27;9(6):e100669. doi: 10.1371/journal.pone.0100669. eCollection 2014. PubMed
Genetics and Genomics of SOST: Functional Analysis of Variants and Genomic Regulation in Osteoblasts. Martinez-Gil N, Roca-Ayats N, Cozar M, Garcia-Giralt N, Ovejero D, Nogues X, Grinberg D, Balcells S. Int J Mol Sci. 2021 Jan 6;22(2). pii: ijms22020489. doi: 10.3390/ijms22020489. PubMed

If you have published an article using this material, please email us at to have your article added to this page.